<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Organizing :: Changing :: Communicating &#187; strategy</title>
	<atom:link href="http://www.turris-consulting.de/wordpress/category/strategy/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.turris-consulting.de/wordpress</link>
	<description>Organizational Change and Business Communication</description>
	<lastBuildDate>Sun, 21 Mar 2010 20:00:00 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Pharma industry change &#8211; Sanofi</title>
		<link>http://www.turris-consulting.de/wordpress/pharma-industry-change-sanofi/</link>
		<comments>http://www.turris-consulting.de/wordpress/pharma-industry-change-sanofi/#comments</comments>
		<pubDate>Mon, 21 Dec 2009 16:46:25 +0000</pubDate>
		<dc:creator>itowers</dc:creator>
				<category><![CDATA[Acquisitions and mergers]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[strategy]]></category>
		<category><![CDATA[Change management]]></category>
		<category><![CDATA[Sanofi]]></category>

		<guid isPermaLink="false">http://www.turris-consulting.de/wordpress/?p=545</guid>
		<description><![CDATA[As if to emphasise what my last post said, today came an announcement from Sanofi, the French pharma company, that they are buying Chattem for $1.9bn. Chattem provides over-the-counter drugs like Gold Bond or Selsun Blue. 
What&#8217;s the rationale for this? Probably Sanofi wants to become less reliant on the blockbuster patented drug business.
]]></description>
			<content:encoded><![CDATA[<p>As if to emphasise what my last post said, today came an announcement from <a href="http://en.sanofi-aventis.com/" target="_blank">Sanofi</a>, the French pharma company, that they are buying Chattem for $1.9bn. Chattem provides over-the-counter drugs like Gold Bond or Selsun Blue. <img class="alignleft size-full wp-image-546" style="margin-left: 5px; margin-right: 5px;" title="Selsun Blue" src="http://www.turris-consulting.de/wordpress/wp-content/uploads/2009/12/mod1_f2.png" alt="Selsun Blue" width="136" height="121" /></p>
<p>What&#8217;s the rationale for this? Probably Sanofi wants to become less reliant on the blockbuster patented drug business.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.turris-consulting.de/wordpress/pharma-industry-change-sanofi/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

